Page last updated: 2024-08-25

rosiglitazone and cortisone

rosiglitazone has been researched along with cortisone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Andrew, R; Homer, NZ; Karpe, F; Stimson, RH; Tan, GD; Wake, DJ; Walker, BR1
Bouhlel, MA; Chinetti-Gbaguidi, G; Copin, C; Derudas, B; Duhem, C; Eeckhoute, J; Lefebvre, P; Neve, B; Noel, B; Seckl, JR; Staels, B1

Trials

1 trial(s) available for rosiglitazone and cortisone

ArticleYear
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:5

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adult; Aged; Cortisone; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Fenofibrate; Gas Chromatography-Mass Spectrometry; Hormone Antagonists; Humans; Hydrocortisone; Hypolipidemic Agents; Insulin Resistance; Kinetics; Liver; Male; Metyrapone; Microdialysis; Middle Aged; Mifepristone; Obesity; PPAR alpha; PPAR gamma; Rosiglitazone; Subcutaneous Fat; Thiazolidinediones

2007

Other Studies

2 other study(ies) available for rosiglitazone and cortisone

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Peroxisome proliferator-activated receptor-γ activation induces 11β-hydroxysteroid dehydrogenase type 1 activity in human alternative macrophages.
    Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:3

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Cells, Cultured; Cortisone; Enzyme Induction; Genes, Reporter; Humans; Hydrocortisone; Inflammation; Interleukin-4; Macrophages; PPAR gamma; Receptors, Glucocorticoid; RNA Interference; Rosiglitazone; Thiazolidinediones; Time Factors; Transfection

2012